Skip to main content


Table 2 Proportional hazard ratios for N0 patients in BC no AST and NKI cohorts

From: Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

Cohort NKI BC no AST
Predictor PCR-based Prosigna PCR-based Prosigna
Luminal B 4.19 3.37 3.47 3.18
HER2-enriched 5.19 4.88 4.78 5.02
Basal-like 2.41 2.45 3.17 2.96
  1. Results generated using the published classifier and the Prosigna classifier